Kazuto Matsunaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazuto Matsunaga has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Tsunahiko Hirano
Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube 755-8505, Japan
10 shared publications - Yoshiaki Minakata
Department of Respiratory Medicine, NHO Wakayama Hospital, 1138 Wada, Mihama-cho, Hidaka-gun, Wakayama 644-0044, Japan
9 shared publications - Hisatoshi Sugiura
Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan
7 shared publications - Keiichiro Akamatsu
Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan
7 shared publications - Masakazu Ichinose
Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
6 shared publications - Tomohiro Ichikawa
Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan
6 shared publications
Latest Publications
- 1 July 2015
- Published by Elsevier in Respiratory Investigation
- Vol. 53 (4) , 137-148
Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells
- 1 July 2015
- Published by Elsevier in Respiratory Investigation
- Vol. 53 (4) , 137-148
Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells
- 5 December 2014
- Published by Elsevier in Respiratory Investigation
- Vol. 53 (2) , 82-85
Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: A multicenter cross-sectional CAP study
- 5 December 2014
- Published by Elsevier in Respiratory Investigation
- Vol. 53 (2) , 82-85
Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: A multicenter cross-sectional CAP study
- 1 July 2014
- Published by Elsevier in Respiratory Medicine
- Vol. 108 (7) , 976-982
Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline
- 1 July 2014
- Published by Elsevier in Respiratory Medicine
- Vol. 108 (7) , 976-982
Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline
- 1 March 2014
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 2 (2) , 172-178.e1
Ongoing Allergic Rhinitis Impairs Asthma Control by Enhancing the Lower Airway Inflammation
- 1 March 2014
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 2 (2) , 172-178.e1
Ongoing Allergic Rhinitis Impairs Asthma Control by Enhancing the Lower Airway Inflammation
- 24 February 2014
- Published by Springer Nature
- p. 225-243
Oxidative Stress and Respiratory Muscle Dysfunction
- 24 February 2014
- Published by Springer Nature
- p. 225-243
Oxidative Stress and Respiratory Muscle Dysfunction
- 1 January 2014
- Published by Elsevier in Respiratory Investigation
- Vol. 52 (1) , 41-48
Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease
- 1 January 2014
- Published by Elsevier in Respiratory Investigation
- Vol. 52 (1) , 41-48
Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease
- 4 October 2013
- Published by IOP Publishing in Journal of Breath Research
- Vol. 7 (4) , 046002
Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD
Nitrative stress is thought to be involved in the inflammatory process in COPD airways, and the alveolar nitric oxide concentration (CAlv) has been reported to be increased. However, the CAlv levels are also regulated by gas diffusion at alveolar sites. The aim of the study was to assess the relationship between the CAlv and pulmonary function in COPD patients, while taking into account the lung diffusion capacity. Twenty stable COPD patients (GOLD stage1/2/3/4 = 6/8/6/0) and 16 healthy subjects took part in this cross-sectional study. Fractional exhaled nitric oxide (FENO), CAlv, and pulmonary functions were measured. Pulmonary function, including single nitrogen washout curve (dN2) and diffusion capacity for carbon monoxide (DLCO), was also evaluated in patients with COPD. The mean FENO levels (20.7 ppb versus 16.3 ppb, p < 0.05) and the mean CAlv levels (6.4 ppb versus 4.2 ppb, p < 0.01) in COPD patients were significantly increased compared to those in HS. The CAlv level in COPD was significantly correlated with dN2, %DLCO/alveolar volume (VA). Using the standard entry method of multivariate analysis to adjust for dN2 and %DLCO/VA, dN2 (β = 0.54, p = 0.005) and %DLCO/VA (β = −0.44, p = 0.018) still showed significant correlations with the CAlv levels. These results suggest that the CAlv could be a useful marker for the small airway dysfunction in COPD. Airway inflammation, including excess nitric oxide generation in the peripheral airways, might be related to the pathophysiology of COPD.
- 4 October 2013
- Published by IOP Publishing in Journal of Breath Research
- Vol. 7 (4) , 046002
Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD
Nitrative stress is thought to be involved in the inflammatory process in COPD airways, and the alveolar nitric oxide concentration (CAlv) has been reported to be increased. However, the CAlv levels are also regulated by gas diffusion at alveolar sites. The aim of the study was to assess the relationship between the CAlv and pulmonary function in COPD patients, while taking into account the lung diffusion capacity. Twenty stable COPD patients (GOLD stage1/2/3/4 = 6/8/6/0) and 16 healthy subjects took part in this cross-sectional study. Fractional exhaled nitric oxide (FENO), CAlv, and pulmonary functions were measured. Pulmonary function, including single nitrogen washout curve (dN2) and diffusion capacity for carbon monoxide (DLCO), was also evaluated in patients with COPD. The mean FENO levels (20.7 ppb versus 16.3 ppb, p < 0.05) and the mean CAlv levels (6.4 ppb versus 4.2 ppb, p < 0.01) in COPD patients were significantly increased compared to those in HS. The CAlv level in COPD was significantly correlated with dN2, %DLCO/alveolar volume (VA). Using the standard entry method of multivariate analysis to adjust for dN2 and %DLCO/VA, dN2 (β = 0.54, p = 0.005) and %DLCO/VA (β = −0.44, p = 0.018) still showed significant correlations with the CAlv levels. These results suggest that the CAlv could be a useful marker for the small airway dysfunction in COPD. Airway inflammation, including excess nitric oxide generation in the peripheral airways, might be related to the pathophysiology of COPD.
- 1 March 2013
- Published by Elsevier in Respiratory Medicine
- Vol. 107 (3) , 355-360
Natural history and risk factors of obstructive changes over a 10-year period in severe asthma
- 1 March 2013
- Published by Elsevier in Respiratory Medicine
- Vol. 107 (3) , 355-360
Natural history and risk factors of obstructive changes over a 10-year period in severe asthma
- 30 October 2012
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 26 (2) , 189-194
Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol
- 30 October 2012
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 26 (2) , 189-194
Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol
- 1 January 2012
- Vol. 61 (1) , 1-9
[Assessment of airway inflammation by exhaled gas and exhaled breath condensate].
- 1 January 2012
- Vol. 61 (1) , 1-9
[Assessment of airway inflammation by exhaled gas and exhaled breath condensate].